Quay Pharma Revenue and Competitors

Deeside, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Quay Pharma's estimated annual revenue is currently $26.7M per year.(i)
  • Quay Pharma's estimated revenue per employee is $201,000

Employee Data

  • Quay Pharma has 133 Employees.(i)
  • Quay Pharma grew their employee count by -12% last year.

Quay Pharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Customer Success & CommercialReveal Email/Phone
3
Analytical ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Quay Pharma?

By far, our most important asset is an exceptional depth of knowledge and experience that enables us to design novel and effective drug delivery systems built on a fundamental scientific and technical understanding of our clients requirements. Quay Pharma offer every client a bespoke approach matched precisely to their needs and circumstances. We know that a university department researching new drug applications has different needs from a major manufacturer developing a new chemical entity, because we work regularly with both. Over the past decade we have successfully developed safe, robust and effective new products for more than 100 clients, across a spectrum of projects that range from hard-to-deliver New Chemical Entities to reformulations of established drugs, many of them now either successfully licensed or in the latter stages of clinical development. We have also helped with the successful development of a wide range of generic products, medical devices and veterinary products. Significantly, we have often devised successful formulations where other companies have failed. Please contact: enquiries@quaypharma.com

keywords:N/A

N/A

Total Funding

133

Number of Employees

$26.7M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Quay Pharma News

2022-04-17 - Liveome draws ?7billion Series A funding < Pharma < ????

... clinical drugs with global contract development and manufacturing organization (CDMO) companies, such as Luina Bio and Quay Pharma.

2022-04-06 - SGS Quay Pharma Partners with Liveome to Develop ...

SGS Quay Pharma was selected for this project because of its proven expertise in product development and clinical supply for therapies derived...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.1M1346%N/A
#2
$300M21910%N/A
#3
$88.7M2784%N/A
#4
$466.2M1850N/AN/A
#5
$2770.6M87188%N/A